- Danaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological Diagnosis
- Curiox Biosystems and Beckman Coulter Life Sciences Announce a Partnership Combining C-FREE™ Technology with DURA Innovations for Hands-Free Washed Sample Preparation for Flow Cytometry
- Danaher Reports First Quarter 2024 Results
- Cepheid Announces World Health Organization Prequalification of Xpert HIV-1 Qualitative Test
- Danaher Schedules First Quarter 2024 Earnings Conference Call
- Cepheid Receives FDA Clearance for Xpert® Xpress GBS
- Danaher to Present at TD Cowen Health Care Conference
- Danaher Commits to Set Science-Based, Net-Zero Greenhouse Gas Emission Reduction Targets
- Danaher Announces Quarterly Dividend
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 260.00 |
---|---|
High | 264.02 |
Low | 259.74 |
Bid | 259.62 |
Offer | 267.32 |
Previous close | 263.46 |
Average volume | 1.89m |
---|---|
Shares outstanding | 740.69m |
Free float | 661.04m |
P/E (TTM) | 45.77 |
Market cap | 184.84bn USD |
EPS (TTM) | 5.45 USD |
Annual div (ADY) | 1.08 USD |
---|---|
Annual div yield (ADY) | 0.42% |
Div ex-date | Mar 27 2024 |
Div pay-date | Apr 26 2024 |
Next div ex-date | Jun 28 2024 |
Next div pay-date | Jul 26 2024 |
Data delayed at least 15 minutes, as of May 16 2024 00:00 BST.
More ▼